BiCNU
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for BiCNU, covering 2008-04-01 to 2017-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]